Transcatheter Valve Treatment: Peri-procedural Management
Progress in the field of interventional cardiology today allows percutaneous treatment of various valve diseases. A growing population of elderly and/or high-risk patients can benefit from a non-surgical approach, with limited periprocedural risk and a minor incidence of adverse events compared to surgery. However, the severity of the clinical picture of these patients and the greater invasiveness and complexity of these procedures compared to conventional interventional cardiology procedures require a higher level of attention to detect and manage an ever growing number of “new” complications accompanying these innovative techniques. Therefore, all physicians involved in the management and care of these patients need to have adequate knowledge and be frequently updated on the pre- and post-procedural management, based on the experience gained day to day. This chapter illustrates various aspects relating to the diagnosis, management, and care of patients before and after novel aortic valve implantation procedures to treat aortic stenosis (AS) and mitral valve repair procedures using the Mitraclip® device to treat mitral regurgitation (MR). Special attention will be focused on the general and specific principles of each technique and the hemodynamic impairment model associated with each valve disease. Table 5.1 summarizes the components of routine care before and after transcatheter aortic valve implantation (TAVI) and Mitraclip® device implantation.
KeywordsMitral Regur Aortic Valve Replacement Pericardial Effusion Transcatheter Aortic Valve Implantation Thrombotic Thrombocytopenic Purpura
Unable to display preview. Download preview PDF.
- 11.Bagai J, Zhao D. Subcutaneous “figure-of-eight” stitch to achieve hemostasis after removal of large-caliber femoral venous sheaths. Cardiac Interventions Today 2008;July/August:22–23.Google Scholar
- 12.NHLBI balloon valvuloplasty registry participants. Percutaneous balloon aortic valvuloplasty. Acute and 30-day follow-up results in 674 patients from the NHLBI balloon valvuloplasty registry. Circulation 1991;84:2383–2397.Google Scholar
- 13.Otto CM, Mickel MC, Kennedy JW et al. Three-year outcome after balloon aortic valvuloplasty. Insights into prognosis of valvular aortic stenosis. Circulation 1994;89:642–650.Google Scholar
- 22.Bonow RO, Carabello BA, Chaterjee K et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to develop guidelines for the management of patients with valvular heart disease). J Am Coll Cardiol 2006;48:e1–148.CrossRefPubMedGoogle Scholar
- 26.Butchart EG, Gohlke-Bärwolf C, Antunes MJ et al; Working Groups on Valvular Heart Disease, Thrombosis, Cardiac Rehabilitation, Exercise Physiology and European Society of Cardiology. Recommendations for the management of patients after heart valve surgery. Eur Heart J 2005;26:2463–2471.CrossRefPubMedGoogle Scholar